Latest filing published 03 Jun 2026 for Bionano Genomics, Inc., €8. Read the official filing
This profile gathers the share dealings of Mark Adamchak in Bionano Genomics, Inc. We count 4 filings; the first trade dates from 15 February 2025 and the latest from 3 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 3 June 2026, the filings show a share grant worth €8 in Bionano Genomics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations